| [September 05, 2013] |
 |
Medical Innovation iTClamp Hemorrhage Control System Used for First Time in United States
SAN ANTONIO --(Business Wire)--
On Thursday, August 29, a 64 year old man near Olive Branch, Mississippi
was trimming tree limbs when his chainsaw got caught in his shirtsleeve
and came down on his left upper arm, leaving a 7 inch long, 1 inch deep
wound that was bleeding uncontrollably. Clinicians at the nearest
hospital determined that he needed air transport to The Regional Medical
Center of Memphis (The MED) for Trauma OR services, and local air
transport service Hospital Wing was called in. Upon arrival, Hospital
Wing flight crew members Jan Weatherred RN and Jennifer Miller EMT-P
immediately remembered an innovative new hemorrhage control device that
had been adopted by the service that very day - the iTClampTM
Hemorrhage Control System - and they put it to use, marking the first
time this device has been used in the United States since it obtained
FDA clearance earlier this summer.
Currently accepted treatment for severe bleeding is typically direct
pressure, hemostatic agents and sometimes tourniquets. But in this
patient's case, these options were either inappropriate or unsuccessful
to stop his bleeding, and the bleeding from the wound remained
uncontrolled when Hospital Wing arrived. Enter the iTClamp.
Within minutes of applying two iTClamps to the wound, the bleeding
stopped, the patient stabilized, and the aircrew was able to transport
him to The MED where surgens sutured him up. Eight hours later, he was
released from the hospital. "The iTClamp provided a quick and easy
solution to an otherwise potentially life threatening injury," commented
Weatherred. Hospital Wing's Director of Education, Jason Clark, spoke
with the patient 48 hours after the accident and the patient reported a
minimal pain level and a slight pressure sensation following application
of the device.
Dr. Joe Holley, one of Hospital Wing's Medical Directors, led the
service's adoption of the iTClamp, and Hospital Wing is the first
service in the United States to deploy the device. "Severe hemorrhage
continues to be a leading cause of morbidity and mortality. The iTClamp
has given us a rapidly deployable means to effectively control these
situations in the field. The iTClamp is quickly applied, portable,
effective, and doesn't disrupt distal blood flow like a tourniquet. The
crew can quickly control life threatening bleeding and proceed with
additional important patient care activities. Hospital Wing has always
led the way in patient care and innovation, and I'm really excited to be
a part of this latest development in patient care."
The iTClamp from iTraumaCare is designed to control severe bleeding - a
leading cause of death in traumatic injury - in seconds. The iTClamp
seals the edges of a wound closed to create a temporary pool of blood
under pressure, which forms a stable clot that mitigates further blood
loss until the wound can be surgically repaired.
Dr. Dennis Filips, the CEO of iTraumaCare and the inventor of the
iTClamp, commented, "To have our first human use in the US turn out so
well is thrilling, and we look forward to getting the iTClamp into the
hands of first responders across the country and around the world."
Hospital Wing, the Mid-South's only non-profit air ambulance service,
began operations in Memphis in 1986 as a consortium of Methodist
Lebonheur Healthcare, Baptist Memorial Healthcare, and The Regional
Medical Center "The MED." Hospital Wing owns seven aircraft and has
bases in Memphis, Brownsville, and Selmer, Tennessee; Oxford,
Mississippi; and Jonesboro, Arkansas. Hospital Wing also provides
helicopter services for Pedi-Flite, the specialty pediatric transport
team from Lebonheur Children's Hospital.
The iTClamp is the first product from iTraumaCare, an emerging medical
device firm based in Edmonton, Canada with global commercialization
headquarters in San Antonio, Texas. iTraumaCare is addressing unmet
needs in the field of emergency medicine by developing, manufacturing,
and commercializing solutions to treat common causes of preventable
death in traumatic injury scenarios.

[ Back To TMCnet.com's Homepage ]
|